Why India Failed to Penalize those Responsible for the Circulation of Substandard Medicines and Vaccines while China Succeeded

The fake drug market is estimated at $200 billion by the World Customs Organization (WCO). The World Health Organization estimates that as many as 30% of all medicines sold in some areas of Asia are fake. Of those surveyed, as many as 67% considered counterfeit medicines were labeled dangerous [1]. Indian pharmaceutical companies suggested that in India’s major cities, one in every five strips of medicines sold is a fake leading to an annual revenue loss of 4-5%. It is also estimated that spurious drugs market growth are faster than the real drug market; it has grown from 10% to 20% of the total market.